methamphetamine has been researched along with Shock, Cardiogenic in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Button, B; Gaudet, J; Kromm, J; Lucyk, SN; Morrison, LK; Warshawski, F; Zuege, D | 1 |
| Chehab, O; Dubrey, S; Ioannou, A; Rice, A; Sawhney, A | 1 |
| Alphonso, N; Marathe, SP; Morwood, J; Perumal, G; Schlapbach, LJ; Venugopal, P | 1 |
| Kandolf, R; Klingel, K; Sandri, M; Schuler, G; Wilde, J | 1 |
| Fernando, H; Stokes, MB; Taylor, AJ | 1 |
| KELLER, ML | 1 |
| Chen, JP | 1 |
| Hong, R; Matsuyama, E; Nur, K | 1 |
1 review(s) available for methamphetamine and Shock, Cardiogenic
| Article | Year |
|---|---|
Methamphetamine-associated acute myocardial infarction and cardiogenic shock with normal coronary arteries: refractory global coronary microvascular spasm.
Topics: Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Coronary Angiography; Coronary Vasospasm; Disease Progression; Electrocardiography; Humans; Male; Methamphetamine; Myocardial Infarction; Shock, Cardiogenic | 2007 |
7 other study(ies) available for methamphetamine and Shock, Cardiogenic
| Article | Year |
|---|---|
Rescue extracorporeal membrane oxygenation therapy in methamphetamine toxicity.
Topics: Extracorporeal Membrane Oxygenation; Female; Humans; Methamphetamine; Narcotics; Shock, Cardiogenic; Substance Abuse, Intravenous; Young Adult | 2018 |
Reverse Takotsubo Cardiomyopathy and Cardiogenic Shock Associated With Methamphetamine Consumption.
Topics: Adult; C-Reactive Protein; Electrocardiography; Emergency Service, Hospital; Fever; Headache; Humans; Male; Methamphetamine; Myocytes, Cardiac; Shock, Cardiogenic; Takotsubo Cardiomyopathy; Ventricular Function, Left; Vomiting | 2017 |
Postoperative catecholamine resistance following fetal methamphetamine exposure.
Topics: Amphetamine-Related Disorders; Cardiotonic Agents; Central Nervous System Stimulants; Dopamine; Drug Resistance; Extracorporeal Membrane Oxygenation; Female; Humans; Hypoplastic Left Heart Syndrome; Infant, Newborn; Male; Maternal Exposure; Methamphetamine; Milrinone; Norwood Procedures; Pregnancy; Risk Factors; Shock, Cardiogenic; Treatment Outcome | 2019 |
["Catecholamine refractory" cardiogenic shock? "Bridging-to-recovery" by implantation of a percutaneous cardiac assist device].
Topics: Adult; Amphetamine-Related Disorders; Biopsy; Cardiomyopathies; Catecholamines; Cooperative Behavior; Drug Resistance; Echocardiography; Epinephrine; Extracorporeal Membrane Oxygenation; Heart-Assist Devices; Home Care Services; Humans; Interdisciplinary Communication; Male; Methamphetamine; Myocarditis; Myocardium; Patient Care Team; Percutaneous Coronary Intervention; Prosthesis Design; Shock, Cardiogenic | 2013 |
Cardiogenic shock secondary to methamphetamine induced cardiomyopathy requiring veno-arterial extra-corporeal membrane oxygenation.
Topics: Adult; Cardiomyopathies; Extracorporeal Membrane Oxygenation; Humans; Male; Methamphetamine; Shock, Cardiogenic | 2016 |
Vasopressor drugs in the treatment of cardiogenic shock.
Topics: Humans; Hypertension; Mephentermine; Metaraminol; Methamphetamine; Myocardial Infarction; Norepinephrine; Phenylephrine; Shock; Shock, Cardiogenic; Vasoconstrictor Agents | 1963 |
Cardiomyopathy associated with the smoking of crystal methamphetamine.
Topics: Adult; Cardiomyopathy, Dilated; Female; Humans; Methamphetamine; Myocardial Infarction; Shock, Cardiogenic; Substance-Related Disorders | 1991 |